May 02, 2024
AstraZeneca Pharmaceuticals LP, et al v. Secretary United States Department of Health and H, et al
Case Number:
24-1819
Court:
Nature of Suit:
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- AstraZeneca PLC
- Center for American Progress
- Justice in Aging
- National Association for the Advancement of Colored People
- UnidosUS
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 08, 2025
3rd Circ. Rejects Challenge To Medicare Drug Price Program
The Third Circuit on Thursday rejected AstraZeneca's challenge to the Medicare drug price negotiation program, ruling that the pharmaceutical giant was unable to show how it is injured by the program's guidance or how it violates its due process rights.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what鈥檚 happening with clients, competitors, practice areas, and industries. 极速赛车 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login